Use of the GUARDANT360 noninvasive tumor sequencing assay on 300 patients across colorectal, melanoma, lung, breast, and prostate cancers and its clinical utility.
AmirAli Talasaz
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Other Remuneration - Guardant Health
Stefanie Mortimer
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Other Remuneration - Guardant Health
Dragan Sebisanovic
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Other Remuneration - Guardant Health
LaiMun Siew
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Other Remuneration - Guardant Health
Aubrey Zapanta
Employment or Leadership Position - Guardant Health
Other Remuneration - Guardant Health
Gangwu Mei
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Other Remuneration - Guardant Health
Ben Schiller
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Other Remuneration - Guardant Health
Helmy Eltoukhy
Employment or Leadership Position - Guardant Health
Stock Ownership - Guardant Health
Other Remuneration - Guardant Health